Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 2/2018

10.03.2018

Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patients

verfasst von: Cindy You, Shishir Sharma, Aakash Bavishi, Christopher A. Groh, Yazan Alia, Basil Saour, Rod Passman

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Hemodialysis (HD) patients have a high risk of sudden death but limited vascular access and high complication rates from transvenous implantable cardioverter-defibrillators (ICDs). Subcutaneous ICDs (S-ICD) may be an alternative, but dynamic ECG changes may result in inappropriate shocks. This study aims to define the screen failure rate for S-ICD in patients pre- and post-HD.

Methods

ECG waveforms were obtained using electrodes mimicking the S-ICD sensing vectors in an unselected test group of chronic HD patients and a control group of ICD-eligible non-dialysis patients. Participants passed screening if their QRS and T-waves fit within the screening template in supine and standing positions in any lead. Test group participants were screened before and after HD and control group patients were screened at two separate time points. HD patients were stratified into the four following groups: (A) passed screening before and after HD, (B) failed screening before but passed after HD, (C) passed screening before but failed after HD, and (D) failed screening before and after HD. Patients in group A passed the screening for ICD implantation, and patients in groups B, C, and D failed the screening for ICD implantation. Control patients were similarly classified by pass/fail status at the two assessment points.

Results

Of the 76 patients enrolled, 51 were HD patients and 25 were controls. Of the 51 HD patients, 43 (84%) were in group A, four participants (8%) were in group B, one (2%) was in group C, and three participants (6%) were in group D. There were no differences in any of the clinical or demographic variables between the pass and fail test HD groups. None of the 25 controls failed the screening at either time point (p = 0.047 vs HD patients).

Conclusions

Overall, HD patients were more likely to fail S-ICD screening compared to non-HD patients (16 v 0%, p = 0.047) and are more likely to do so prior to HD. Patients on HD should be screened at multiple time points around the dialytic interval to reduce the risk of inappropriate shocks.
Literatur
1.
Zurück zum Zitat Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, et al. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis. 2013;61:A7, e1–476.CrossRef Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, et al. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis. 2013;61:A7, e1–476.CrossRef
2.
Zurück zum Zitat Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–9.CrossRefPubMed Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–9.CrossRefPubMed
3.
Zurück zum Zitat Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112–9.CrossRefPubMed Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112–9.CrossRefPubMed
4.
Zurück zum Zitat Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int. 2006;69:2268–73.CrossRefPubMed Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int. 2006;69:2268–73.CrossRefPubMed
5.
Zurück zum Zitat Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2007;58:409–17.CrossRef Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2007;58:409–17.CrossRef
6.
Zurück zum Zitat Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Goldberger J, et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis. 2007;49:656–63.CrossRefPubMed Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Goldberger J, et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis. 2007;49:656–63.CrossRefPubMed
7.
Zurück zum Zitat Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA, National Cardiovascular Data R. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm. 2009;6:1565–71.CrossRefPubMed Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA, National Cardiovascular Data R. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm. 2009;6:1565–71.CrossRefPubMed
8.
Zurück zum Zitat Hreybe H, Razak E, Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol. 2007;30:1091–5.CrossRefPubMed Hreybe H, Razak E, Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol. 2007;30:1091–5.CrossRefPubMed
9.
Zurück zum Zitat Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011;58:409–17.CrossRefPubMed Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011;58:409–17.CrossRefPubMed
10.
Zurück zum Zitat Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36–44.CrossRefPubMed Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36–44.CrossRefPubMed
11.
Zurück zum Zitat Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944–53.CrossRefPubMed Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944–53.CrossRefPubMed
12.
Zurück zum Zitat El-Chami MF, Levy M, Kelli HM, Casey M, Hoskins MH, Goyal A, Langberg JJ, Patel A, Delurgio D, Lloyd MS, Leon AR, Merchant FM. Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis. J Cardiovasc Electrophysiol 2015. El-Chami MF, Levy M, Kelli HM, Casey M, Hoskins MH, Goyal A, Langberg JJ, Patel A, Delurgio D, Lloyd MS, Leon AR, Merchant FM. Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis. J Cardiovasc Electrophysiol 2015.
13.
Zurück zum Zitat Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial. 2008;21:300–7.CrossRefPubMed Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial. 2008;21:300–7.CrossRefPubMed
14.
Zurück zum Zitat Poulikakos DM, Malik MPM. Challenges of ECG monitoring and ECG interpretations in dialysis units. J Electrocardiol. 2016;49:855–9.CrossRefPubMed Poulikakos DM, Malik MPM. Challenges of ECG monitoring and ECG interpretations in dialysis units. J Electrocardiol. 2016;49:855–9.CrossRefPubMed
15.
Zurück zum Zitat Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, et al. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1361–6.CrossRefPubMed Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, et al. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1361–6.CrossRefPubMed
16.
Zurück zum Zitat Pun PH, Hellkamp AS, Sanders GD, Middleton JP, Hammill SC, Al-Khalidi HR, et al. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. Nephrol Dial Transplant. 2015;30:829–35.CrossRefPubMed Pun PH, Hellkamp AS, Sanders GD, Middleton JP, Hammill SC, Al-Khalidi HR, et al. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. Nephrol Dial Transplant. 2015;30:829–35.CrossRefPubMed
17.
Zurück zum Zitat Olde Nordkamp LR, Warnaars JL, Kooiman KM, de Groot JR, Rosenmoller BR, Wilde AA, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014;25:494–9.CrossRefPubMed Olde Nordkamp LR, Warnaars JL, Kooiman KM, de Groot JR, Rosenmoller BR, Wilde AA, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014;25:494–9.CrossRefPubMed
18.
Zurück zum Zitat Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace. 2014;16:1015–21.CrossRefPubMed Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace. 2014;16:1015–21.CrossRefPubMed
19.
Zurück zum Zitat Wu VC, Lin LY, Wu KD. QT interval dispersion in dialysis patients. Nephrology (Carlton). 2005;10:109–12.CrossRef Wu VC, Lin LY, Wu KD. QT interval dispersion in dialysis patients. Nephrology (Carlton). 2005;10:109–12.CrossRef
20.
Zurück zum Zitat Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A. Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs. 1993;16:31–6.CrossRefPubMed Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A. Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs. 1993;16:31–6.CrossRefPubMed
21.
Zurück zum Zitat Dillon JJ, DeSimone CV, Sapir Y, Somers VK, Dugan JL, Bruce CJ, et al. Noninvasive potassium determination using a mathematically processed ECG: proof of concept for a novel “blood-less, blood test”. J Electrocardiol. 2015;48:12–8.CrossRefPubMed Dillon JJ, DeSimone CV, Sapir Y, Somers VK, Dugan JL, Bruce CJ, et al. Noninvasive potassium determination using a mathematically processed ECG: proof of concept for a novel “blood-less, blood test”. J Electrocardiol. 2015;48:12–8.CrossRefPubMed
Metadaten
Titel
Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patients
verfasst von
Cindy You
Shishir Sharma
Aakash Bavishi
Christopher A. Groh
Yazan Alia
Basil Saour
Rod Passman
Publikationsdatum
10.03.2018
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2018
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-018-0343-1

Weitere Artikel der Ausgabe 2/2018

Journal of Interventional Cardiac Electrophysiology 2/2018 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.